The novel reversible LSD1 inhibitor SP-2577 promotes anti-tumor immunity in SWItch/Sucrose-NonFermentable (SWI/SNF) complex mutated ovarian cancerRaffaella Soldi, Sunil Sharma, Trason Thode et al.|PLoS ONE|2020Cited by 82
The novel reversible LSD1 inhibitor SP-2577 promotes anti-tumor immunity in SWItch/Sucrose-NonFermentable (SWI/SNF) complex mutated ovarian cancerRaffaella Soldi, Sunil Sharma, Alexis Weston et al.|bioRxiv (Cold Spring Harbor Laboratory)|2020Cited by 19